Clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders
- Year invested 2010
- Investment Stage Public/PIPES
- Sectors
- Investment Status Historic
- Website rigel.com
- Company Status IPO/Public (NASDAQ: RIGL)